Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved ...

WEST PALM BEACH, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTCID: FOXO) (“FOXO” or the “Company”), announces the closing of the acquisition of Vector Biosource Inc. (“Vector”).

TAMPA, FL and BLOOMINGTON, IN - (Sept. 8, 2021) - Vector Solutions, the leading provider of industry-focused software solutions for training, workforce management and risk communications, has acquired ...

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...

AC vector technology continues to increase in servo applications, such as in an automotive timing-chain manufacturing plant recently serviced by distributor Eastern Bearings Inc., Waltham, Mass. The ...

From 6-9th January, Vector will be showcasing practical solutions for developing and operating Software-Defined Vehicles ...